# Boehmeria Nivea Extract (BNE-RRC) Reverses Epithelial-Mesenchymal Transition and Inhibits Anchorage-Independent Growth in Tumor Cells

## TL;DR

This study shows that Boehmeria Nivea extract reverses cancer cell changes linked to tumor spread and stops cancer cells from growing independently.

## Contribution

The study demonstrates BNE-RRC's ability to reverse EMT and inhibit anchorage-independent growth in tumor cells.

## Key findings

- BNE-RRC induces epithelial-like morphology in KB cells, reversing EMT to MET.
- Sustained BNE-RRC treatment maintains epithelial status even after treatment withdrawal.
- BNE-RRC inhibits cancer cell growth, migration, and invasion.

## Abstract

The epithelial–mesenchymal transition (EMT) phenotype, identified as a significant clinical indicator in regard to cancer, manifests as a biological process wherein cells transition from having epithelial to mesenchymal characteristics. Physiologically, EMT plays a crucial role in tissue remodeling, promoting healing, repair, and responses to various types of tissue damage. This study investigated the impact of BNE-RRC on oral cancer cells (KB) and revealed its significant effects on cancer cell growth, migration, invasion, and the EMT. BNE-RRC induces the epithelial-like morphology in KB cells, effectively reversing the EMT to a mesenchymal–epithelial transition (MET). Extraordinarily, sustained culturing of cancer cells with BNE-RRC for 14 days maintains an epithelial status even after treatment withdrawal, suggesting that BNE-RRC is a potential therapeutic agent for cancer. These findings highlight the promise of BNE-RRC as a comprehensive therapeutic agent for cancer treatment that acts by inhibiting cancer cell growth, migration, and invasion while also orchestrating a reversal of the EMT process. In this study, we propose that BNE-RRC could be an effective agent for cancer treatment.